After moving -0.5% during today's afternoon session, Pfizer is now trading at a price of $38.27 per share. On average, analysts give it a target price of $48.73.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Pfizer Investors Should Consider This:
-
Pfizer has moved -20.6% over the last year.
-
The company has a price to earnings growth (PEG) ratio of -0.78. A number between 0 and 1 could mean that the market is undervaluing Pfizer's estimated growth potential
-
Its Price to Book (P/B) ratio is 2.25
Understanding Pfizer's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | 100,330,000 | 28,714,000 | 37.15 | 49.26 |
| 2021-12-31 | 81,288,000 | 30,232,000 | 24.89 | 19.09 |
| 2020-12-31 | 41,908,000 | 24,456,000 | 20.9 | -22.3 |
| 2019-12-31 | 51,750,000 | 27,610,000 | 26.9 | n/a |
Pfizer's operating margins have averaged 27.5% over the last 4 years, which is significantly higher than the Pharmaceutical industry average of 12.02%. In addition, the firm benefits from a 8.4% yearly operating margin growth rate.
